Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.91%142.68M | -8.77%118.71M | 1.05%134.87M | -0.07%585.56M | 59.02%193.33M | -14.63%128.65M | -20.88%130.12M | -10.57%133.47M | 48.99%585.97M | -10.90%121.57M |
| Cost of revenue | 10.06%138.41M | -8.89%115.99M | 0.51%131.12M | -2.22%574.16M | 45.19%190.04M | -15.68%125.76M | -21.06%127.31M | -10.58%130.46M | 40.99%587.18M | -2.46%130.89M |
| Gross profit | 47.75%4.27M | -3.06%2.73M | 24.49%3.75M | 1,039.82%11.4M | 135.23%3.28M | 85.27%2.89M | -11.76%2.81M | -10.25%3.01M | 94.76%-1.21M | -512.76%-9.32M |
| Operating expense | 83.24%2.24M | 633.11%2.15M | 7.28%2.71M | -34.53%5.46M | -22.23%2.78M | -20.12%1.22M | -83.74%293K | 27.16%2.53M | -0.34%8.34M | 67.18%3.57M |
| Selling and administrative expenses | 1.58%2.38M | -1.56%2.33M | 7.28%2.71M | 9.43%8.66M | -22.23%2.78M | 18.57%2.34M | 18.09%2.37M | 3.90%2.53M | 1.65%7.91M | 129.72%3.57M |
| -General and administrative expense | 1.58%2.38M | -1.56%2.33M | 7.28%2.71M | 9.43%8.66M | -22.23%2.78M | 18.57%2.34M | 18.09%2.37M | 3.90%2.53M | 1.65%7.91M | 129.72%3.57M |
| Other operating expenses | ---- | ---- | ---- | 5.06%914K | ---- | ---- | ---- | ---- | 16.03%870K | ---- |
| Total other operating income | -87.59%139K | -91.09%185K | ---- | 824.49%4.11M | ---- | 151.69%1.12M | 913.17%2.08M | -3.60%429K | 164.72%445K | ---- |
| Operating profit | 21.75%2.03M | -77.02%579K | 114.23%1.04M | 162.22%5.94M | 103.92%505K | 5,463.33%1.67M | 81.82%2.52M | -64.57%485K | 69.71%-9.55M | -10,730.56%-12.89M |
| Net non-operating interest income (expenses) | -33.83%133K | 708.70%140K | -20.69%115K | -8.46%552K | 118.85%23K | 271.79%201K | 84.87%-23K | 272.62%145K | 354.09%603K | -131.95%-122K |
| Non-operating interest income | -32.44%227K | 34.66%237K | -25.70%211K | -6.78%1M | --23K | --336K | --176K | --284K | 70.55%1.08M | ---- |
| Non-operating interest expense | -30.37%94K | -51.26%97K | -30.94%96K | -0.24%412K | ---- | 15.38%135K | 30.92%199K | 65.48%139K | -13.52%413K | -46.63%122K |
| Total other finance cost | ---- | ---- | ---- | -35.00%39K | ---- | ---- | ---- | ---- | 192.41%60K | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 62.68%-449K | 91.09%-1.2M | ||||||||
| Less:Write off | ---- | ---- | ---- | -62.68%449K | ---- | ---- | ---- | ---- | -91.09%1.2M | ---- |
| Other non-operating income (expenses) | 156.55%372K | 196.65%4.52M | -12.73%377K | 145K | 1.52M | 432K | ||||
| Income before tax | 15.78%2.17M | -71.21%719K | 96.90%1.53M | 159.56%6.05M | 107.19%905K | 2,249.43%1.87M | 102.35%2.5M | -39.69%775K | 77.39%-10.15M | -172.78%-12.58M |
| Income tax | 13.14%577K | -65.34%227K | 71.26%435K | 356.40%1.68M | 113.39%265K | 1,861.54%510K | 84.51%655K | -30.03%254K | 94.23%-656K | -123.54%-1.98M |
| Net income | 16.76%1.59M | -73.29%492K | 109.40%1.09M | 145.96%4.36M | 106.04%640K | 1,303.54%1.36M | 109.56%1.84M | -43.49%521K | 71.69%-9.49M | -184.48%-10.6M |
| Net income continuous operations | 16.76%1.59M | -73.29%492K | 109.40%1.09M | 145.96%4.36M | 106.04%640K | 1,303.54%1.36M | 109.56%1.84M | -43.49%521K | 71.69%-9.49M | -184.48%-10.6M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 16.76%1.59M | -73.29%492K | 109.40%1.09M | 145.96%4.36M | 106.04%640K | 1,303.54%1.36M | 109.56%1.84M | -43.49%521K | 71.69%-9.49M | -184.48%-10.6M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 16.76%1.59M | -73.29%492K | 109.40%1.09M | 145.96%4.36M | 106.04%640K | 1,303.54%1.36M | 109.56%1.84M | -43.49%521K | 71.69%-9.49M | -184.48%-10.6M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 6.98%0.0046 | -75.86%0.0014 | 93.75%0.0031 | 145.67%0.0137 | 105.37%0.0018 | 1,175.00%0.0043 | 107.14%0.0058 | -44.83%0.0016 | 71.64%-0.03 | -186.32%-0.0335 |
| Diluted earnings per share | 6.98%0.0046 | -75.86%0.0014 | 93.75%0.0031 | 145.67%0.0137 | 105.37%0.0018 | 1,175.00%0.0043 | 107.14%0.0058 | -44.83%0.0016 | 71.64%-0.03 | -186.32%-0.0335 |
| Dividend per share | 0 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.